首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1871511

2021-2031年北美人类微生物组市场报告：范围、细分、动态和竞争分析

North America Human Microbiome Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年09月01日 | 出版商:

The Insight Partners | 英文 129 Pages | 订单完成后即时交付

价格

简介目录图表

预计北美人类微生物组市场将大幅成长，到 2031 年将达到约 28.1182 亿美元，高于 2023 年的 6.5489 亿美元，2023 年至 2031 年的年复合成长率(CAGR) 为 20.0%。

执行摘要和市场分析

北美是表观遗传学和微生物组研究的领先地区，其中美国占据最大的市场份额，其次是加拿大。该地区人类微生物组市场的成长受多种因素驱动，包括广泛的研究计划、生物技术资金的增加、消费者健康意识的提高，以及对益生菌和益生元在慢性病管理方面日益增长的需求。此外，该地区高度重视开发以微生物组为基础的疗法，相关会议数量不断增加，以及当地主要企业的存在，所有这些因素都有望促进市场成长和收入提升。

市场区隔分析

北美人类微生物组市场可按类型、应用和疾病类型细分：

类型：市场分为产品和软体/服务，其中产品在 2023 年占据更大的市场份额。产品部分可再细分为益生菌和益生元。
应用领域：市场分为治疗、诊断和研究三个部分，其中治疗领域在 2023 年占据了市场份额的主导地位。
疾病类型：市场分为肥胖症、糖尿病、自体免疫疾病、癌症、胃肠道 (GIT) 问题等类别，其中 GIT 议题在 2023 年将引领市场。

市场展望

政府的各项措施和支持计画在人类微生物组市场的发展中发挥着至关重要的作用。大量的资金和拨款通常用于微生物组研究，这加速了新疗法、设备和诊断方法的发展。例如，美国国立卫生研究院 (NIH) 已承诺在五年内投入 1.15 亿美元，用于支持人类微生物组计划，该计划旨在增进对人类健康的了解，并改善疾病的预防、诊断和治疗。此类资金促进了创新和商业化，尤其有利于微生物组领域的初创企业和中小企业 (SME)。此外，建立基于微生物组产品的监管框架可以简化新疗法的引入流程，确保其安全性和有效性，从而增强消费者信心并提高市场接受度。

国家概况

北美人类微生物组市场涵盖美国、加拿大和墨西哥，其中美国在2023年占据最大的市场份额。微生物组研究在生物技术领域的应用正在迅速扩展，并逐渐成为治疗多种慢性疾病的重要手段。这促使私人投资增加，并推动了环境微生物组工程的发展。过去十年，美国在人类微生物组研究方面投资约10亿美元，其中约20%的资金用于人类微生物组计画（HMP）。 HMP于2007年启动，旨在为人类微生物组研究创建必要的科研资源，从而为微生物组研究和疗法开发做出重大贡献。

第十四章：附录

简介目录图表

Product Code: TIPRE00003319

The North American human microbiome market is projected to grow significantly, reaching approximately USD 2,811.82 million by 2031, up from USD 654.89 million in 2023, reflecting a compound annual growth rate (CAGR) of 20.0% from 2023 to 2031.

Executive Summary and Market Analysis

North America stands as the leading region for epigenetics and microbiome research, with the United States commanding the largest market share, followed by Canada. The growth of the human microbiome market in this region is driven by several factors, including extensive research initiatives, increased funding for biotechnology, heightened health awareness among consumers, and a growing demand for probiotics and prebiotics aimed at managing chronic diseases. Additionally, there is a strong emphasis on developing microbiome-based therapeutics, an increase in relevant conferences, and the presence of key local players, all of which are expected to enhance market growth and revenue generation.

Market Segmentation Analysis

The North American human microbiome market can be segmented by type, application, and disease type:

Type: The market is divided into products and software/services, with products holding a larger market share in 2023. The product segment is further categorized into probiotics and prebiotics.
Application: The market is segmented into therapeutics, diagnostics, and research, with therapeutics dominating the market share in 2023.
Disease Type: The market is classified into categories such as obesity, diabetes, autoimmune disorders, cancer, gastrointestinal (GIT) issues, and others, with GIT issues leading the market in 2023.

Market Outlook

Government initiatives and support programs play a crucial role in the growth of the human microbiome market. Substantial funding and grants are often allocated for microbiome research, which accelerates the development of new treatments, devices, and diagnostics. For example, the National Institutes of Health (NIH) has committed USD 115 million over five years to support the Human Microbiome Project, which aims to enhance understanding of human health and improve disease prevention, diagnosis, and treatment. Such funding fosters innovation and commercialization, particularly for startups and small-to-medium enterprises (SMEs) in the microbiome sector. Furthermore, the establishment of regulatory frameworks for microbiome-based products can streamline the introduction of new treatments, ensuring safety and efficacy, which in turn boosts consumer confidence and market acceptance.

Country Insights

The North American human microbiome market includes the United States, Canada, and Mexico, with the US holding the largest market share in 2023. The application of microbiome research is rapidly expanding within biotechnology, emerging as a vital therapeutic approach for various chronic diseases. This has led to increased private investment and advancements in environmental microbiome engineering. Over the past decade, the US has invested around USD 1 billion in human microbiome research, with approximately 20% of this funding directed towards the Human Microbiome Project (HMP). Launched in 2007, the HMP aims to create essential research resources for studying the human microbiome, resulting in significant contributions to microbiome research and therapy development.

Recent Developments

The demand for human microbiome therapeutics in the US is further fueled by product launches and regulatory approvals. For instance, in November 2022, Ferring Pharmaceuticals received FDA approval for REBYOTA, a first-in-class microbiota-based live biotherapeutic designed to prevent recurrent Clostridioides difficile infections in adults following antibiotic treatment.

Company Profiles

Key players in the human microbiome market include MaaT Pharma, Ferring Holdings SA, AOBiome Therapeutics Inc, Finch Therapeutics Group Inc, Seres Therapeutics Inc, Merck & Co Inc, Rebiotix, Inc., Yakult Honsha Co., Ltd., IFF Nutrition & Biosciences, and Synthetic Biologics, Inc. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. North America Human Microbiome Market Landscape

4.1 Overview
4.2 PEST Analysis

5. North America Human Microbiome Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Significant Investments by Key Market Players
- 5.1.2 Government Initiatives
5.2 Market Restraints
- 5.2.1 Challenges During Production of Microbiome
5.3 Market Opportunities
- 5.3.1 Robust Investment in Research and Development
5.4 Future Trends
- 5.4.1 Emergence of Precision Medicine
5.5 Impact of Drivers and Restraints:

6. North America Human Microbiome Market - Analysis

6.1 North America Human Microbiome Market Revenue (US$ Million), 2021-2031
6.2 North America Human Microbiome Market Forecast Analysis

7. North America Human Microbiome Market Analysis - by Type

7.1 Product
- 7.1.1 Overview
- 7.1.2 Product: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Software and Services
- 7.2.1 Overview
- 7.2.2 Software and Services: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Human Microbiome Market Analysis - by Application

8.1 Therapeutics
- 8.1.1 Overview
- 8.1.2 Therapeutics: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Diagnostics
- 8.2.1 Overview
- 8.2.2 Diagnostics: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Research
- 8.3.1 Overview
- 8.3.2 Research: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Human Microbiome Market Analysis - by Disease Type

9.1 Obesity
- 9.1.1 Overview
- 9.1.2 Obesity: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Diabetes
- 9.2.1 Overview
- 9.2.2 Diabetes: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Autoimmune Disorder
- 9.3.1 Overview
- 9.3.2 Autoimmune Disorder: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Cancer
- 9.4.1 Overview
- 9.4.2 Cancer: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5 GIT
- 9.5.1 Overview
- 9.5.2 GIT: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Human Microbiome Market - Country Analysis

10.1 North America
- 10.1.1 North America Human Microbiome Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 North America Human Microbiome Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 United States: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 United States: North America Human Microbiome Market Share - by Type
    - 10.1.1.2.2 United States: North America Human Microbiome Market Share - by Product
    - 10.1.1.2.3 United States: North America Human Microbiome Market Share - by Application
    - 10.1.1.2.4 United States: North America Human Microbiome Market Share - by Disease Type
  - 10.1.1.3 Canada: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Canada: North America Human Microbiome Market Share - by Type
    - 10.1.1.3.2 Canada: North America Human Microbiome Market Share - by Product
    - 10.1.1.3.3 Canada: North America Human Microbiome Market Share - by Application
    - 10.1.1.3.4 Canada: North America Human Microbiome Market Share - by Disease Type
  - 10.1.1.4 Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Mexico: North America Human Microbiome Market Share - by Type
    - 10.1.1.4.2 Mexico: North America Human Microbiome Market Share - by Product
    - 10.1.1.4.3 Mexico: North America Human Microbiome Market Share - by Application
    - 10.1.1.4.4 Mexico: North America Human Microbiome Market Share - by Disease Type

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Human Microbiome Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Ferring Holdings SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 AOBiome Therapeutics Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Finch Therapeutics Group Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Financial Overview
- 13.4.4 SWOT Analysis
- 13.4.5 Key Developments
13.5 Seres Therapeutics Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck & Co Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Yakult Honsha Co., Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Rebiotix, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 IFF Nutrition & Biosciences
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Synthetic Biologics, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About Us
14.2 List of Abbreviations

简介目录图表

List Of Tables

Table 1. North America Human Microbiome Market Segmentation
Table 2. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
Table 4. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
Table 5. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease Type
Table 6. North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 7. United States: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 8. United States: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. United States: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. United States: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 11. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 13. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 15. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 16. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 17. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 18. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 19. Recent Organic Growth Strategies in the Human Microbiome Market
Table 20. Recent Inorganic Growth Strategies in the Human Microbiome Market
Table 21. List of Abbreviations

List Of Figures

Figure 1. North America Human Microbiome Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. North America Human Microbiome Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Human Microbiome Market Revenue (US$ Million), 2021-2031
Figure 6. North America Human Microbiome Market Share (%) - by Type (2023 and 2031)
Figure 7. Product: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Software and Services: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. North America Human Microbiome Market Share (%) - by Application (2023 and 2031)
Figure 10. Therapeutics: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Diagnostics: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. Research: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 13. North America Human Microbiome Market Share (%) - by Disease Type (2023 and 2031)
Figure 14. Obesity: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Diabetes: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Autoimmune Disorder: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. Cancer: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. GIT: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 19. Others: North America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 20. North America Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United States: North America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 22. Canada: North America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 23. Mexico: North America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 24. Heat Map Analysis by Key Players
Figure 25. Company Positioning and Concentration
Figure 26. Growth Strategies in the Human Microbiome Market